These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
441 related items for PubMed ID: 25728212
41. Identification and Validation of PLOD2 as an Adverse Prognostic Biomarker for Oral Squamous Cell Carcinoma. Sun Y, Wang S, Zhang X, Wu Z, Li Z, Ding Z, Huang X, Chen S, Jing Y, Zhang X, Ding L, Song Y, Sun G, Ni Y. Biomolecules; 2021 Dec 07; 11(12):. PubMed ID: 34944486 [Abstract] [Full Text] [Related]
42. Transforming growth factor-β1 activates ΔNp63/c-Myc to promote oral squamous cell carcinoma. Hu L, Liu J, Li Z, Wang C, Nawshad A. Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Oct 07; 122(4):460-482.e4. PubMed ID: 27567435 [Abstract] [Full Text] [Related]
43. MRTF-A/SRF signaling suppresses invasion of oral squamous cell carcinoma. Yang D, Yang D, He Y, Liu J, Song Y, Zhou Y, Jiang L, Zeng X, Xu X, Xu H, Li J, Dan H. Oral Dis; 2024 May 07; 30(4):1919-1934. PubMed ID: 37154247 [Abstract] [Full Text] [Related]
44. Pituitary tumor-transforming gene 1 (PTTG1) is overexpressed in oral squamous cell carcinoma (OSCC) and promotes migration, invasion and epithelial-mesenchymal transition (EMT) in SCC15 cells. Zhang E, Liu S, Xu Z, Huang S, Tan X, Sun C, Lu L. Tumour Biol; 2014 Sep 07; 35(9):8801-11. PubMed ID: 24879625 [Abstract] [Full Text] [Related]
45. MUC1 gene silencing inhibits proliferation, invasion, and migration while promoting apoptosis of oral squamous cell carcinoma cells. Zhang AM, Chi XH, Bo ZQ, Huang XF, Zhang J. Biosci Rep; 2019 Sep 30; 39(9):. PubMed ID: 31439759 [Abstract] [Full Text] [Related]
46. Overexpression of ATAD2 indicates Poor Prognosis in Oral Squamous Cell Carcinoma. Wang XL, Wang S, Wu ZZ, Yang QC, Li H, Xiong HG, Wan SC, Sun ZJ. Int J Med Sci; 2020 Sep 30; 17(11):1598-1609. PubMed ID: 32669963 [Abstract] [Full Text] [Related]
47. EZH2 promotes invasion and tumour glycolysis by regulating STAT3 and FoxO1 signalling in human OSCC cells. Zheng M, Cao MX, Luo XJ, Li L, Wang K, Wang SS, Wang HF, Tang YJ, Tang YL, Liang XH. J Cell Mol Med; 2019 Oct 30; 23(10):6942-6954. PubMed ID: 31368152 [Abstract] [Full Text] [Related]
48. Epiregulin reprograms cancer-associated fibroblasts and facilitates oral squamous cell carcinoma invasion via JAK2-STAT3 pathway. Wang Y, Jing Y, Ding L, Zhang X, Song Y, Chen S, Zhao X, Huang X, Pu Y, Wang Z, Ni Y, Hu Q. J Exp Clin Cancer Res; 2019 Jun 24; 38(1):274. PubMed ID: 31234944 [Abstract] [Full Text] [Related]
53. HOXA10 controls proliferation, migration and invasion in oral squamous cell carcinoma. Carrera M, Bitu CC, de Oliveira CE, Cervigne NK, Graner E, Manninen A, Salo T, Coletta RD. Int J Clin Exp Pathol; 2015 Jun 24; 8(4):3613-23. PubMed ID: 26097543 [Abstract] [Full Text] [Related]
54. Naa10p and IKKα interaction regulates EMT in oral squamous cell carcinoma via TGF-β1/Smad pathway. Lv S, Luo T, Yang Y, Li Y, Yang J, Xu J, Zheng J, Zeng Y. J Cell Mol Med; 2021 Jul 24; 25(14):6760-6772. PubMed ID: 34060226 [Abstract] [Full Text] [Related]
55. The Hippo transducer TAZ promotes epithelial to mesenchymal transition and cancer stem cell maintenance in oral cancer. Li Z, Wang Y, Zhu Y, Yuan C, Wang D, Zhang W, Qi B, Qiu J, Song X, Ye J, Wu H, Jiang H, Liu L, Zhang Y, Song LN, Yang J, Cheng J. Mol Oncol; 2015 Jun 24; 9(6):1091-105. PubMed ID: 25704916 [Abstract] [Full Text] [Related]
57. Sodium Phenylbutyrate Inhibits Tumor Growth and the Epithelial-Mesenchymal Transition of Oral Squamous Cell Carcinoma In Vitro and In Vivo. Qian K, Sun L, Zhou G, Ge H, Meng Y, Li J, Li X, Fang X. Cancer Biother Radiopharm; 2018 May 24; 33(4):139-145. PubMed ID: 29658787 [Abstract] [Full Text] [Related]